RESUMEN
Neurovascular involvement is a frequent occurring reported in COVID-19 patients. However, spontaneous hematomas of the corpus callosum are exceptionally seen. The authors of this article aim to report an unusual case of corpus callosum hematoma in a COVID-19 patient and discuss potential etiologies and mechanisms responsible for intracranial hemorrhage.
Asunto(s)
COVID-19/complicaciones , Cuerpo Calloso/patología , Hematoma/diagnóstico , Hemorragias Intracraneales/diagnóstico , Cuerpo Calloso/virología , Hematoma/etiología , Hematoma/virología , Humanos , Hemorragias Intracraneales/etiología , Hemorragias Intracraneales/virología , Masculino , Persona de Mediana EdadRESUMEN
BACKGROUND: Seoul virus (SEOV) is a Hantavirus and the causative pathogen of Hemorrhagic Fever with Renal Syndrome (HFRS). Diagnosing SEOV infection is difficult because the clinical presentations are often undistinguishable from other viral or bacterial infections. In addition, diagnostic tools including serological and molecular assays are not readily available in the clinical settings. CASE REPORT: A 57-year-old male presented with fever and a sudden loss of consciousness in November 2019. Computed tomography (CT) scan showed subdural hematoma, subfalcine herniation, and brain infarction. He developed thrombocytopenia and elevated transaminases, but no rashes or obvious kidney damage. He reported having a rat bite. HFRS was suspected. The Hantavirus IgG was positive, and the metagenomic next-generation sequencing (mNGS) detected SEOV sequences directly in the blood. CONCLUSION: This report highlights the importance of suspecting SEOV infection in febrile patients with thrombocytopenia and elevated liver enzymes despite the absence of hemorrhagic manifestations of skin and renal syndromes. Next-generation sequencing is a powerful tool for pathogen detection. Intracranial hemorrhage and brain infarction as extrarenal manifestations of HFRS are rare but possible as demonstrated in this case.
Asunto(s)
Fiebre Hemorrágica con Síndrome Renal/complicaciones , Fiebre Hemorrágica con Síndrome Renal/virología , Hemorragias Intracraneales/virología , Virus Seoul/genética , Fiebre Hemorrágica con Síndrome Renal/diagnóstico , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Hemorragias Intracraneales/diagnóstico , Hemorragias Intracraneales/diagnóstico por imagen , Masculino , Persona de Mediana EdadAsunto(s)
COVID-19/complicaciones , Hemorragias Intracraneales/virología , Anciano , COVID-19/diagnóstico , COVID-19/terapia , Cuidados Críticos/métodos , Enfermedad Crítica , Humanos , Hemorragias Intracraneales/diagnóstico por imagen , Imagen por Resonancia Magnética , Masculino , Persona de Mediana EdadRESUMEN
BACKGROUND: Little is known about the effect of the Coronavirus disease 2019 pandemic on stroke care and the impact of the epidemic on acute stroke hospitalizations has not been described. METHODS: We analyze the stroke admission rate in three hospitals in New York City from January 1, 2020 through April 17, 2020, identifying all cases of acute ischemic stroke, intraparenchymal hemorrhage and subarachnoid hemorrhage. RESULTS: We confirmed 518 cases of out-of-hospital stroke. During the baseline period up to February 25, 2020, the daily stroke admission rate was stable, with the slope of the regression describing the number of admissions over time equal to -0.33 (seâ¯=â¯1.21), not significantly different from 0 (pâ¯=â¯0.79), with daily admissions averaging 41. During the pandemic period, the slope was -4.4 (seâ¯=â¯1.00); i.e., the number of stroke admissions decreased an average of 4.4 per week, (pâ¯=â¯0.005), with weekly admissions averaging 23, a reduction of 44% versus baseline. This general result was not different by patient age, sex, or race/ethnicity. CONCLUSIONS: The weekly stroke admission rate started declining two weeks prior to the local surge of coronavirus admissions. The consequences of lack of diagnosis and treatment of a large proportion of acute stroke patients are likely severe and lasting.
Asunto(s)
Infecciones por Coronavirus/terapia , Atención a la Salud/tendencias , Hemorragias Intracraneales/terapia , Admisión del Paciente/tendencias , Neumonía Viral/terapia , Accidente Cerebrovascular/terapia , Anciano , Betacoronavirus/patogenicidad , COVID-19 , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/virología , Femenino , Interacciones Microbiota-Huesped , Humanos , Hemorragias Intracraneales/diagnóstico , Hemorragias Intracraneales/epidemiología , Hemorragias Intracraneales/virología , Masculino , Persona de Mediana Edad , Ciudad de Nueva York/epidemiología , Pandemias , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , Neumonía Viral/virología , Pronóstico , SARS-CoV-2 , Accidente Cerebrovascular/diagnóstico , Accidente Cerebrovascular/epidemiología , Accidente Cerebrovascular/virología , Hemorragia Subaracnoidea/epidemiología , Hemorragia Subaracnoidea/terapia , Factores de TiempoRESUMEN
OBJECTIVE: To highlight the increased risk of hemorrhagic stroke secondary to postulated COVID-19 mediated vasculopathy with concomitant ECMO related bleeding complications. BACKGROUND: COVID-19 has shown to be a systemic illness, not localized to the respiratory tract and lung parenchyma. Stroke is a common neurological complication. In particular, critically ill patients on ECMO are likely at higher risk of developing hemorrhagic stroke. CASE PRESENTATION: 38-year-old man presented with fever, cough, and shortness of breath. Due to severe respiratory failure, he required ECMO support. Subsequently, he was found to have left temporal intraparenchymal hemorrhage. Overall, his clinical course improved, and he was discharged with minimal neurological deficits. CONCLUSION: Although intracranial hemorrhage is a known complication of ECMO, patients with COVID-19 infection may be at a higher risk of cerebrovascular complications due to vasculopathy.
Asunto(s)
Betacoronavirus/patogenicidad , Infecciones por Coronavirus/terapia , Oxigenación por Membrana Extracorpórea , Hemorragias Intracraneales/etiología , Pulmón/virología , Neumonía Viral/terapia , Accidente Cerebrovascular/etiología , Adulto , COVID-19 , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/fisiopatología , Infecciones por Coronavirus/virología , Oxigenación por Membrana Extracorpórea/efectos adversos , Interacciones Huésped-Patógeno , Humanos , Hemorragias Intracraneales/diagnóstico por imagen , Hemorragias Intracraneales/virología , Pulmón/fisiopatología , Masculino , Pandemias , Neumonía Viral/complicaciones , Neumonía Viral/fisiopatología , Neumonía Viral/virología , Factores de Riesgo , SARS-CoV-2 , Índice de Severidad de la Enfermedad , Accidente Cerebrovascular/diagnóstico por imagen , Accidente Cerebrovascular/virología , Resultado del TratamientoRESUMEN
OBJECTIVE: We aim to characterize the incidence, risk for mortality, and identify risk factors for mortality in patients presenting with hemorrhage and COVID-19. METHODS: This retrospective cohort study included a cohort of patients admitted to one of three major hospitals of our healthcare network including, an academic medical center and comprehensive stroke center, which accepts transfers for complex cases from eight community hospitals, during March 1 to May 1, 2020. All patients that received imaging of the neuroaxis and had positive PCR testing for COVID-19 were identified and reviewed by an attending neuroradiologist. Demographics and comorbidities were recorded. Biomarkers were recorded from the day of the hemorrhagic event. Vital signs from the day of the hemorrhagic event mechanical ventilation orders at admission were recorded. Imaging findings were divided into 5 subtypes; acute subdural hematoma (SDH), subarachnoid hemorrhage (SAH), multi-compartmental hemorrhage (MCH), multi-focal intracerebral hemorrhage (MFH), and focal intracerebral hemorrhage (fICH). Outcomes were recorded as non-routine discharge and mortality. RESULTS: We found a total of 35 out of 5227 patients with COVID-19 that had hemorrhage of some kind. Mortality for the entire cohort was 45.7 % (nâ¯=â¯16). SDH patients had a mortality rate of 35.3 % (nâ¯=â¯6), SAH had a mortality of 50 % (nâ¯=â¯1), MCH patients had a mortality of 71.4 % (nâ¯=â¯5), MFH patients had a mortality of 50 % (nâ¯=â¯2), fICH patients had a mortality of 40 % (nâ¯=â¯2). Patients with severe pulmonary COVID requiring mechanical ventilation (OR 10.24 [.43-243.12] pâ¯=â¯0.015), with INRâ¯>â¯1.2 on the day of the hemorrhagic event (OR 14.36 [1.69-122.14] pâ¯=â¯0.015], and patients presenting with spontaneous vs. traumatic hemorrhage (OR 6.11 [.31-118.89] pâ¯=â¯0.023) had significantly higher risk for mortality. CONCLUSIONS: Hemorrhagic presentations with COVID-19 are a rare but serious way in which the illness can manifest. It is important for neurosurgeons to realize that patients can present with these findings without primary pulmonary symptoms, and that severe pulmonary symptoms, elevated INR, and spontaneous hemorrhagic presentations is associated with increased risk for mortality.
Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/mortalidad , Hemorragias Intracraneales/epidemiología , Hemorragias Intracraneales/virología , Neumonía Viral/complicaciones , Neumonía Viral/mortalidad , Adulto , Anciano , Anciano de 80 o más Años , COVID-19 , Infecciones por Coronavirus/diagnóstico , Femenino , Humanos , Incidencia , Hemorragias Intracraneales/diagnóstico , Masculino , Persona de Mediana Edad , Pandemias , Neumonía Viral/diagnóstico , Estudios Retrospectivos , Factores de Riesgo , SARS-CoV-2 , Tasa de SupervivenciaRESUMEN
BACKGROUND: The coronavirus disease 2019 is associated with neurological manifestations including stroke. OBJECTIVES: We present a case series of coronavirus disease 2019 patients from two institutions with acute cerebrovascular pathologies. In addition, we present a pooled analysis of published data on large vessel occlusion in the setting of coronavirus disease 2019 and a concise summary of the pathophysiology of acute cerebrovascular disease in the setting of coronavirus disease 2019. METHODS: A retrospective study across two institutions was conducted between 20 March 2020 and 20 May 2020, for patients developing acute cerebrovascular disease and diagnosed with coronavirus disease 2019. We performed a literature review using the PubMed search engine. RESULTS: The total sample size was 22 patients. The mean age was 59.5 years, and 12 patients were female. The cerebrovascular pathologies were 17 cases of acute ischemic stroke, 3 cases of aneurysm rupture, and 2 cases of sinus thrombosis. Of the stroke and sinus thrombosis patients, the mean National Institute of Health Stroke Scale was 13.8 ± 8.0, and 16 (84.2%) patients underwent a mechanical thrombectomy procedure. A favorable thrombolysis in cerebral infarction score was achieved in all patients. Of the 16 patients that underwent a mechanical thrombectomy, the mortality incidence was five (31.3%). Of all patients (22), three (13.6%) patients developed hemorrhagic conversion requiring decompressive surgery. Eleven (50%) patients had a poor functional status (modified Rankin Score 3-6) at discharge, and the total mortality incidence was eight (36.4%). CONCLUSIONS: Despite timely intervention and favorable reperfusion, the mortality rate in coronavirus disease 2019 patients with large vessel occlusion was high in our series and in the pooled analysis. Notable features were younger age group, involvement of both the arterial and venous vasculature, multivessel involvement, and complicated procedures due to the clot consistency and burden.
Asunto(s)
Betacoronavirus , Isquemia Encefálica/epidemiología , Isquemia Encefálica/virología , Infecciones por Coronavirus/complicaciones , Hemorragias Intracraneales/epidemiología , Hemorragias Intracraneales/virología , Neumonía Viral/complicaciones , Enfermedad Aguda , Adulto , Anciano , Isquemia Encefálica/diagnóstico , COVID-19 , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Femenino , Humanos , Hemorragias Intracraneales/diagnóstico , Masculino , Persona de Mediana Edad , Pandemias , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , Estudios Retrospectivos , SARS-CoV-2 , Tasa de SupervivenciaAsunto(s)
Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/fisiopatología , Hemorragias Intracraneales/virología , Neumonía Viral/complicaciones , Neumonía Viral/fisiopatología , Betacoronavirus/patogenicidad , COVID-19 , Femenino , Humanos , Persona de Mediana Edad , Pandemias , SARS-CoV-2RESUMEN
RATIONALE: Intracranial hemorrhage occurs infrequently in Japanese encephalitis (JE), and even less frequently with hemorrhage occurring twice. In this report, we describe the clinical features and outcomes of a patient with confirmed JE combined with hemorrhage twice. PATIENT CONCERNS: The patient, a 71-year-old Asian woman, was admitted to the hospital with symptoms of hemiplegia following fever and diarrhea. Soon her condition worsened and a decreased level of consciousness, respiratory failure, and paralysis of extremities occurred.The brain diffusion-weighted imaging sequence showed suspicious abnormal signals in bilateral thalami. Japanese encephalitis virus immunoglobulin M antibody was detected in her serum and cerebrospinal fluid samples, so the patient was diagnosed with JE. During treatment, her condition became aggravated and the brain computed tomography (CT) scan showed multiple lobar hemorrhages. One month later, the multiple lobar hemorrhages occurred again, as observed by a brain CT scan. DIAGNOSIS: JE with multiple intracranial hemorrhages. INTERVENTIONS: The patient was treated comprehensively, including surgery, lowering her intracranial pressure and ventilator-assisted breathing. OUTCOMES: One month later, the patient underwent another surgical procedure for intracranial hemorrhage and suffered a serious neurological disorder. LESSONS: Severe intracranial hemorrhage may occur in elderly patients with JE, especially in those with poor vascular condition. Therefore, when treating such patients, great caution, as well as early detection and prevention, should be taken in case of the occurrence of severe intracranial hemorrhage.
Asunto(s)
Virus de la Encefalitis Japonesa (Especie) , Encefalitis Japonesa/complicaciones , Hemorragias Intracraneales/virología , Anciano , Femenino , HumanosRESUMEN
We report the case of a newly-diagnosed HIV-positive patient with varicella zoster virus aneurysmal vasculopathy confirmed on intrathecal antibody testing, despite a negative Cerebrospinal fluid (CSF) Varicella Zoster Virus (VZV) Polymerase Chain Reaction (PCR). This highlights the importance of prompt treatment with antiviral and steroid therapy in the presence of clinical or radiological suspicion whilst awaiting further confirmatory testing.
Asunto(s)
Encéfalo/irrigación sanguínea , Encéfalo/diagnóstico por imagen , Enfermedades Arteriales Cerebrales/diagnóstico por imagen , Encefalitis por Varicela Zóster/complicaciones , Seropositividad para VIH/diagnóstico , Aneurisma Intracraneal/diagnóstico por imagen , Hemorragias Intracraneales/etiología , Infección por el Virus de la Varicela-Zóster/diagnóstico , Adulto , Antirretrovirales/administración & dosificación , Antivirales/administración & dosificación , Angiografía por Tomografía Computarizada , Encefalitis por Varicela Zóster/tratamiento farmacológico , Femenino , Seropositividad para VIH/tratamiento farmacológico , Herpesvirus Humano 3/aislamiento & purificación , Humanos , Hemorragias Intracraneales/diagnóstico por imagen , Hemorragias Intracraneales/virología , Imagen por Resonancia Magnética , Prednisolona/administración & dosificación , Resultado del Tratamiento , Infección por el Virus de la Varicela-Zóster/tratamiento farmacológicoRESUMEN
We report a case of fetal cerebellar hemorrhage and hypoplasia, identified by fetal MRI after intrauterine blood transfusion at 21 weeks' gestation for treatment of severe anemia due to congenital Parvovirus infection. Postnatal MRI confirmed atrophy of bilateral cerebellar hemispheres and inferior vermis. Cerebellar capillaries may be extremely susceptible to hemodynamic changes in the setting of intrauterine blood transfusion due to severe anemia. Although the correlation between fetal intracranial anomalies and Parvovirus infection remains unclear, in this population, a detailed evaluation of the brain parenchyma should be considered prior to and after intrauterine blood transfusion.
Asunto(s)
Anemia/virología , Cerebelo/anomalías , Enfermedades Fetales/virología , Hemorragias Intracraneales/virología , Malformaciones del Sistema Nervioso/virología , Infecciones por Parvoviridae/congénito , Adulto , Anemia/terapia , Transfusión de Sangre Intrauterina , Cerebelo/diagnóstico por imagen , Cerebelo/virología , Discapacidades del Desarrollo/diagnóstico por imagen , Discapacidades del Desarrollo/virología , Imagen de Difusión por Resonancia Magnética , Femenino , Enfermedades Fetales/diagnóstico por imagen , Humanos , Hemorragias Intracraneales/diagnóstico por imagen , Malformaciones del Sistema Nervioso/diagnóstico por imagen , Infecciones por Parvoviridae/complicaciones , Infecciones por Parvoviridae/diagnóstico por imagen , EmbarazoRESUMEN
The human parechovirus (HPeV), mainly genotype 3, may cause severe illness in young infants and neonates, including sepsis-like illness and central nervous system (CNS) infection. We lack data concerning the impact and symptoms of HPeV infection in infants in Austria. The aim of the study is to evaluate the spectrum of symptoms and findings in infants with the parechovirus in Vienna and its environs. Patients younger than 3 months of age, with clinically suspected sepsis-like illness or CNS infection and a positive polymerase chain reaction (PCR) for HPeV, were included in the study. Medical records were analyzed retrospectively. Twenty patients were included in the study from 2009 to 2013. The most frequent manifestations were fever and neurological symptoms (89 and 80 %, respectively). Fifty percent of the infants had white blood cell counts out of range. The most notable aspect was cerebral hemorrhage in three neonates, which has not been reported earlier in association with HPeV infection. CONCLUSION: In Austria, HPeV is a relevant pathogen in sepsis-like disease in infants. The clinical presentation is similar to that described in other studies; cerebral hemorrhage is a new aspect. WHAT IS KNOWN: ⢠Parechovirus infection can cause severe illness in infants. ⢠Symptoms have been described to involve all organs; sepsis-like signs, fever, and irritability are most frequent. WHAT IS NEW: ⢠Also in Austria, HPeV plays an important role in severe illnesses in infants. ⢠Severe intracranial hemorrhage is described as a new finding.
Asunto(s)
Infecciones del Sistema Nervioso Central/virología , Hemorragias Intracraneales/virología , Parechovirus/aislamiento & purificación , Infecciones por Picornaviridae/virología , Austria/epidemiología , Infecciones del Sistema Nervioso Central/diagnóstico , Infecciones del Sistema Nervioso Central/epidemiología , Femenino , Humanos , Lactante , Recién Nacido , Hemorragias Intracraneales/diagnóstico , Hemorragias Intracraneales/epidemiología , Masculino , Infecciones por Picornaviridae/diagnóstico , Infecciones por Picornaviridae/epidemiología , Reacción en Cadena de la Polimerasa , ARN Viral/genética , Estudios Retrospectivos , SepsisRESUMEN
BACKGROUND: The varicella zoster virus (VZV) is a highly neurotropic virus that, after the primary infection, remains latent in the nerve cells and can reactivate many years later, resulting in various conditions affecting the central nervous system, such as vasculopathy and stroke. METHODS: We report on a review of the published literature that included all case reports identified via PubMed and an additional unpublished case of VZV vasculopathy. All epidemiological, clinical, laboratory, imaging, virologic, treatment and outcome data collected are described. RESULTS: Of the 62 patients, 41.6% were immunocompromised. Ischemic stroke occurred in 77.2% of the patients, comprising cases of isolated (37.1%) and multifocal stroke (17.7%). Multifocal, ischemic and hemorrhagic stroke was only described in the newly reported case. The magnetic resonance imaging results were normal in 2.9% of the cases. The vascular studies (angiography and magnetic resonance angiography [MRA]) revealed signs of angiitis in 74.4% of the cases; the small arteries were involved in 38.5% of the cases, large arteries in 17.7% and mixed in 43.5%. For 95.2% of the patients, the cerebrospinal fluid (CSF) was positive for VZV IgG antibodies, and for 46.1% of the patients, the CSF was positive for polymerase chain reaction (PCR); however, the diagnosis was confirmed in only 3 of 6 biopsies. DISCUSSION: VZV vasculopathy can occur in both immunocompetent and immunosuppressed patients. Neuroimaging can reveal stroke and angiitis, and the detection of VZV-specific IgG antibodies in the CSF is a reliable and highly sensitive diagnostic tool. The multifocal nature of VZV vasculopathy makes biopsy a test with low sensitivity and high morbidity.
Asunto(s)
Herpes Zóster/complicaciones , Herpesvirus Humano 3/patogenicidad , Hemorragias Intracraneales/etiología , Hemorragias Intracraneales/virología , Adulto , Infarto Cerebral/etiología , Infarto Cerebral/virología , Femenino , Humanos , Angiografía por Resonancia Magnética , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos XRESUMEN
BACKGROUND: The extent to which susceptibility to brain hemorrhage is derived from blood-derived factors or stromal tissue remains largely unknown. We have developed an inducible model of CD8 T cell-initiated blood-brain barrier (BBB) disruption using a variation of the Theiler's murine encephalomyelitis virus (TMEV) model of multiple sclerosis. This peptide-induced fatal syndrome (PIFS) model results in severe central nervous system (CNS) vascular permeability and death in the C57BL/6 mouse strain, but not in the 129 SvIm mouse strain, despite the two strains' having indistinguishable CD8 T-cell responses. Therefore, we hypothesize that hematopoietic factors contribute to susceptibility to brain hemorrhage, CNS vascular permeability and death following induction of PIFS. METHODS: PIFS was induced by intravenous injection of VP2121-130 peptide at 7 days post-TMEV infection. We then investigated brain inflammation, astrocyte activation, vascular permeability, functional deficit and microhemorrhage formation using T2*-weighted magnetic resonance imaging (MRI) in C57BL/6 and 129 SvIm mice. To investigate the contribution of hematopoietic cells in this model, hemorrhage-resistant 129 SvIm mice were reconstituted with C57BL/6 or autologous 129 SvIm bone marrow. Gadolinium-enhanced, T1-weighted MRI was used to visualize the extent of CNS vascular permeability after bone marrow transfer. RESULTS: C57BL/6 and 129 SvIm mice had similar inflammation in the CNS during acute infection. After administration of VP2121-130 peptide, however, C57BL/6 mice had increased astrocyte activation, CNS vascular permeability, microhemorrhage formation and functional deficits compared to 129 SvIm mice. The 129 SvIm mice reconstituted with C57BL/6 but not autologous bone marrow had increased microhemorrhage formation as measured by T2*-weighted MRI, exhibited a profound increase in CNS vascular permeability as measured by three-dimensional volumetric analysis of gadolinium-enhanced, T1-weighted MRI, and became moribund in this model system. CONCLUSION: C57BL/6 mice are highly susceptible to microhemorrhage formation, severe CNS vascular permeability and morbidity compared to the 129 SvIm mouse. This susceptibility is transferable with the bone marrow compartment, demonstrating that hematopoietic factors are responsible for the onset of brain microhemorrhage and vascular permeability in immune-mediated fatal BBB disruption.
Asunto(s)
Linfocitos T CD8-positivos/fisiología , Infecciones por Cardiovirus/complicaciones , Hemorragias Intracraneales/etiología , Animales , Astrocitos/efectos de los fármacos , Barrera Hematoencefálica , Trasplante de Médula Ósea/métodos , Linfocitos T CD8-positivos/efectos de los fármacos , Permeabilidad Capilar/efectos de los fármacos , Proteínas de la Cápside/efectos adversos , Modelos Animales de Enfermedad , Citometría de Flujo , Fluoresceína-5-Isotiocianato/metabolismo , Proteína Ácida Fibrilar de la Glía/metabolismo , Hematínicos , Hemorragias Intracraneales/cirugía , Hemorragias Intracraneales/virología , Imagen por Resonancia Magnética , Ratones , Ratones Endogámicos , Actividad Motora/fisiología , Prueba de Desempeño de Rotación con Aceleración Constante , Theilovirus/patogenicidad , Proteínas Virales/efectos adversosRESUMEN
Pathological studies would aid in finding the real causes of death and in outlining adequate strategies for treatment regarding patients with poor clinical outcome of influenza A H1N1 swine flu. We describe the autopsy findings of six cases of influenza A H1N1 swine flu. The lungs in these cases had an alveolitis with hyaline membranes. Immunohistochemistry for influenza was positive only in lungs (in pneumocytes, in macrophages, in some multinucleate cells in alveoli, and in blood vessel walls) of two cases. Disseminated petechial brain hemorrhage was observed in four of the cases and focally in one case. Focal myocarditis was observed in one case. Coagulation infarcts (ischemic) were observed in the pancreas of two cases and in the spleen of two cases. Our results indicate that there was marked replication of the virus in alveoli in the more recently infected cases, which could explain the extensive diffuse alveolar damage. In our cases, there were important vascular phenomena that resulted in hemorrhage and thrombosis, but without marked decrease of platelet count and coagulation cascade disruptions. This would be attributed to hemodynamic disruption. However, it is possible that the hemorrhagic petechial lesions in the brain are due to vascular lesions or to an increase of endothelial permeability.
Asunto(s)
Subtipo H1N1 del Virus de la Influenza A/patogenicidad , Gripe Humana/patología , Pulmón/patología , Adulto , Autopsia , Encéfalo/patología , Femenino , Humanos , Inmunohistoquímica , Infarto/patología , Infarto/virología , Gripe Humana/mortalidad , Gripe Humana/virología , Hemorragias Intracraneales/patología , Hemorragias Intracraneales/virología , Pulmón/irrigación sanguínea , Pulmón/virología , Masculino , Persona de Mediana Edad , Miocarditis/patología , Miocarditis/virología , Miocardio/patología , Páncreas/irrigación sanguínea , Páncreas/patología , Bazo/irrigación sanguínea , Bazo/patología , Adulto JovenAsunto(s)
Dengue/complicaciones , Encefalomielitis Aguda Diseminada/etiología , Encefalomielitis Aguda Diseminada/virología , Hemorragias Intracraneales/etiología , Hemorragias Intracraneales/virología , Adulto , Encéfalo/patología , Encéfalo/virología , Imagen de Difusión por Resonancia Magnética/métodos , Encefalomielitis Aguda Diseminada/complicaciones , Humanos , Hemorragias Intracraneales/complicaciones , MasculinoRESUMEN
Epstein-Barr virus (EBV) encephalitis is a rare neurological complication, usually only reported in pediatric patients. We present a 20-year-old, previously healthy male who developed hemorrhagic encephalitis caused by EBV. He was admitted to our hospital with a 1-week history of fever, diarrhea, headache, and confusion. Brain T2-weighted MRI showed a focal area of increased signal in the right temporal lobe. Brain MRI and CT scans on day 2 revealed progression of the lesion, with partial hemorrhagic change, acute brain swelling, and severe midline shift. The patient underwent external decompression and external ventricular drainage. EBV DNA was identified in brain biopsy specimens by polymerase chain reaction. The postoperative course was uneventful. To our knowledge, this is the second report of hemorrhagic EBV encephalitis in an adult.
Asunto(s)
Encefalitis Viral/patología , Encefalitis Viral/virología , Infecciones por Virus de Epstein-Barr/complicaciones , Leucoencefalitis Hemorrágica Aguda/patología , Leucoencefalitis Hemorrágica Aguda/virología , Enfermedad Aguda , Factores de Edad , Antivirales/uso terapéutico , Biopsia , Encéfalo/diagnóstico por imagen , Encéfalo/patología , Encéfalo/virología , Edema Encefálico/diagnóstico por imagen , Edema Encefálico/patología , Edema Encefálico/virología , Confusión/etiología , Craneotomía , ADN Viral/genética , Descompresión Quirúrgica , Diarrea/etiología , Progresión de la Enfermedad , Encefalitis Viral/diagnóstico por imagen , Fiebre/etiología , Cefalea/etiología , Herpesvirus Humano 4/genética , Humanos , Hemorragias Intracraneales/diagnóstico por imagen , Hemorragias Intracraneales/patología , Hemorragias Intracraneales/virología , Leucoencefalitis Hemorrágica Aguda/diagnóstico por imagen , Imagen por Resonancia Magnética , Masculino , Lóbulo Temporal/diagnóstico por imagen , Lóbulo Temporal/patología , Lóbulo Temporal/virología , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Ventriculostomía , Adulto JovenAsunto(s)
Encéfalo/irrigación sanguínea , Arterias Cerebrales/virología , Hepatitis C/complicaciones , Hemorragias Intracraneales/virología , Vasculitis del Sistema Nervioso Central/complicaciones , Vasculitis del Sistema Nervioso Central/virología , Anciano , Encéfalo/diagnóstico por imagen , Encéfalo/patología , Arterias Cerebrales/diagnóstico por imagen , Arterias Cerebrales/patología , Enfermedad Crónica , Trastornos de la Conciencia/etiología , Trastornos de la Conciencia/patología , Trastornos de la Conciencia/fisiopatología , Crioglobulinemia/fisiopatología , Crioglobulinemia/virología , Progresión de la Enfermedad , Resultado Fatal , Femenino , Humanos , Hemorragias Intracraneales/diagnóstico por imagen , Hemorragias Intracraneales/patología , Microcirculación/diagnóstico por imagen , Microcirculación/patología , Microcirculación/virología , Polineuropatías/fisiopatología , Polineuropatías/virología , Convulsiones/etiología , Convulsiones/patología , Convulsiones/fisiopatología , Tomografía Computarizada por Rayos X , Vasculitis del Sistema Nervioso Central/patologíaRESUMEN
Since vitamin K2 (VitK2) syrup prophylaxis has become a routine measure for neonates and young infants, the incidence of vitamin K deficiency (VitK-D) in infancy has markedly decreased. However, we recently experienced 2 infantile cases of VitK deficiency, in whom intracranial hemorrhage (ICH) was the first clinical sign of CMV hepatitis. Case 1 is a breast-fed boy who received VitK2 syrup orally at birth and at the age of 1 month. He did not suckle well and developed a generalized tonic convulsion twice at the age of 8 weeks. Case 2 is a mixed-fed boy who also received VitK2 syrup twice but developed vomiting and drowsiness at the age of 4 months. In both cases, laboratory tests showed anemia, leukocytosis, liver dysfunction with cholestasis, and coagulopathy, consistent with VitK-D abnormality. Their serological analyses showed that cytomegalovirus (CMV) IgG and IgM were both positive. In case 1, CMV DNA was positive, as judged by the PCR method. In case 2, CMV antigenemia was positive. Hence we diagnosed these two patients as having VitK-D ICH caused by CMV hepatitis with cholestasis. CMV hepatitis is a risk factor of VitK-D ICH.